Getting the annual RSV shot and other important vaccines is a fantastic way to safeguard yourself and your family as winter ...

The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...

The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...

The NHS is urging eligible patients to protect themselves this winter by getting vaccinated against respiratory syncytial ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV) -- which typically causes mild, cold-like symptoms in most adults but can be deadly for ...

A new study published today in JAMA Network Open shows that respiratory syncytial virus (RSV) was associated with a ...

Image by Arek Socha from Pixabay November 12, 2024 - By Lorna Fernandes - As fall arrives, so does respiratory syncytial ...

The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical ...

Wisconsin Department of Health Services (DHS) data show only 17% of Wisconsinites have received a flu shot this season, and ...

Q3 results confirms that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (PFE) and GSK (GSK), is ...